These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 30358811)

  • 41. Procalcitonin guidance in patients with lower respiratory tract infections: a systematic review and meta-analysis.
    Hey J; Thompson-Leduc P; Kirson NY; Zimmer L; Wilkins D; Rice B; Iankova I; Krause A; Schonfeld SA; DeBrase CR; Bozzette S; Schuetz P
    Clin Chem Lab Med; 2018 Jul; 56(8):1200-1209. PubMed ID: 29715176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Procalcitonin-guided antibiotic therapy: an expert consensus.
    Bartoletti M; Antonelli M; Bruno Blasi FA; Casagranda I; Chieregato A; Fumagalli R; Girardis M; Pieralli F; Plebani M; Rossolini GM; Sartelli M; Viaggi B; Viale P; Viscoli C; Pea F
    Clin Chem Lab Med; 2018 Jul; 56(8):1223-1229. PubMed ID: 29874192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.
    Maravić-Stojković V; Lausević-Vuk L; Jović M; Ranković A; Borzanović M; Marinković J
    Srp Arh Celok Lek; 2011; 139(11-12):736-42. PubMed ID: 22338468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials.
    Schuetz P; Bolliger R; Merker M; Christ-Crain M; Stolz D; Tamm M; Luyt CE; Wolff M; Schroeder S; Nobre V; Reinhart K; Branche A; Damas P; Nijsten M; Deliberato RO; Verduri A; Beghé B; Cao B; Shehabi Y; Jensen JS; Beishuizen A; de Jong E; Briel M; Welte T; Mueller B
    Expert Rev Anti Infect Ther; 2018 Jul; 16(7):555-564. PubMed ID: 29969320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria.
    Yan ST; Sun LC; Jia HB; Gao W; Yang JP; Zhang GQ
    Am J Emerg Med; 2017 Apr; 35(4):579-583. PubMed ID: 27979420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An investigation of the effects of procalcitonin testing on antimicrobial prescribing in respiratory tract infections in an Irish university hospital setting: a feasibility study.
    O'Riordan F; Shiely F; Byrne S; O'Brien D; Palmer B; Dahly D; O'Connor TM; Curran D; Fleming A
    J Antimicrob Chemother; 2019 Nov; 74(11):3352-3361. PubMed ID: 31325313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PROCALCITONIN GUIDED ANTIBIOTIC STEWARDSHIP: A BALKAN EXPERT CONSENSUS STATEMENT.
    Janković R; Stojanović M; Božov H; Domi R; Ivančan V; Karišik M; Mojsova Mijovska M; Jakupović Smajić J; Šoštarič M
    Acta Clin Croat; 2023 Apr; 62(1):36-44. PubMed ID: 38304372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
    Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
    Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Procalcitonin-guided antibiotic therapy for pediatrics with infective disease: A updated meta-analyses and trial sequential analysis.
    Li P; Liu J; Liu J
    Front Cell Infect Microbiol; 2022; 12():915463. PubMed ID: 36211950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of a Procalcitonin-guided Antibiotic Treatment Algorithm in the Pediatric Intensive Care Unit.
    Katz SE; Crook J; Gillon J; Stanford JE; Wang L; Colby JM; Banerjee R
    Pediatr Infect Dis J; 2021 Apr; 40(4):333-337. PubMed ID: 33181782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: An updated meta-analysis.
    Li Z; Yuan X; Yu L; Wang B; Gao F; Ma J
    Medicine (Baltimore); 2019 Aug; 98(32):e16775. PubMed ID: 31393400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Procalcitonin-Guided Antibiotic Therapy Reduces Antibiotic Use for Lower Respiratory Tract Infections in a United States Medical Center: Results of a Clinical Trial.
    Townsend J; Adams V; Galiatsatos P; Pearse D; Pantle H; Masterson M; Kisuule F; Jacob E; Kiruthi C; Ortiz P; Agbanlog A; Jurao R; Stern S; Nayak S; Melgar M; Sama J; Irwin J; Mazidi C; Psoter K; McKenzie R
    Open Forum Infect Dis; 2018 Dec; 5(12):ofy327. PubMed ID: 30619913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment of sepsis patients].
    Xu XL; Yan FD; Yu JQ; Chen QH; Lin H; Zheng RQ
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):343-346. PubMed ID: 28219190
    [No Abstract]   [Full Text] [Related]  

  • 54. Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial.
    Lima SS; Nobre V; de Castro Romanelli RM; Clemente WT; da Silva Bittencourt HN; Melo AC; Salomão LC; Serufo JC
    Ann Hematol; 2016 Jun; 95(7):1169-76. PubMed ID: 27118539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial.
    Daneman N; Rishu AH; Xiong W; Bagshaw SM; Cook DJ; Dodek P; Hall R; Kumar A; Lamontagne F; Lauzier F; Marshall JC; Martin CM; McIntyre L; Muscedere J; Reynolds S; Stelfox HT; Fowler RA;
    Trials; 2015 Apr; 16():173. PubMed ID: 25903783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
    Tosoni A; Paratore M; Piscitelli P; Addolorato G; De Cosmo S; Mirijello A;
    Panminerva Med; 2020 Mar; 62(1):54-62. PubMed ID: 31729202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting.
    Lee CC; Kwa ALH; Apisarnthanarak A; Feng JY; Gluck EH; Ito A; Karuniawati A; Periyasamy P; Pratumvinit B; Sharma J; Solante R; Swaminathan S; Tyagi N; Vu DM; Zirpe K; Schuetz P
    Clin Chem Lab Med; 2020 Nov; 58(12):1983-1991. PubMed ID: 31926074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of procalcitonin testing to a targeted audit-and-feedback strategy on prescribed durations of therapy for community-acquired pneumonia.
    Clark LT; Beuschel TS; Buss PM; Jameson AP; Dumkow LE
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115202. PubMed ID: 33007583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procalcitonin-guided diagnosis and antibiotic stewardship revisited.
    Sager R; Kutz A; Mueller B; Schuetz P
    BMC Med; 2017 Jan; 15(1):15. PubMed ID: 28114931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.